Skip Navigation

Japanese Journal of Clinical Oncology 2005 35(4):207-213; doi:10.1093/jjco/hyi067
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chen, W.-T.
Right arrow Articles by Chai, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.-T.
Right arrow Articles by Chai, C.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2005 Foundation for Promotion of Cancer Research

Hypoxia-inducible Factor-1{alpha} is Associated with Risk of Aggressive Behavior and Tumor Angiogenesis in Gastrointestinal Stromal Tumor

Wan-Tzu Chen1, Chih-Jen Huang2, Ming-Tsang Wu3, Sheau-Fang Yang1, Yue-Chiu Su1 and Chee-Yin Chai1

1 Department of Pathology and 2 Department of Radiation Therapy, Kaohsiung Medical University Chung-Ho Memorial Hospital and 3 Graduate Institute of Occupational Safety and Health, Kaohsiung Medical University, Kaohsiung, Taiwan

For reprints and all correspondence: Chee-Yin Chai, Department of Pathology, Kaohsiung Medical University Chung-Ho Memorial Hospital, No. 100, Tzyou 1st Road, Kaohsiung City 807, Taiwan. E-mail: cychai{at}kmu.edu.tw

Received December 20, 2004; accepted March 9, 2005

Background: The objective of this study was to evaluate the relationship of HIF-1{alpha} expression and tumor angiogenesis, recurrence/distant metastasis, and its value in the prediction of aggressive behavior of gastrointestinal stromal tumor (GIST).

Methods: Paraffin-embedded specimens from 62 patients with GIST were divided into two groups, low risk (n = 31) and high risk (n = 31) according to the tumor size, mitotic count and proliferating cell nuclear antigen (PCNA) index. We investigated the expression of the HIF-1{alpha} and analyzed correlation with tumor angiogenesis monitored by expression of vascular endothelial growth factor (VEGF) and tumor microvessel density using immunohistochemical staining. The data were analyzed with {chi}2 test or Fisher's exact test and multivariate test.

Results: There were statistically significant differences between high risk (29/31; 93.5%) and low risk (8/31; 25.8%) of GIST in high expression of HIF-1{alpha} (P<0.0001). In addition, the incidence of recurrence/distant metastasis was significantly higher in cases of high HIF-1{alpha} expression (12/35; 34.3%) than in cases of low HIF-1{alpha} expression (1/24; 4.2%)(P = 0.009). Moreover, high VEGF expression (37/43; 86.0%) and microvessel density (30/32; 93.8%) were significantly higher in high HIF-1{alpha} expression tumors than in low-expression tumors (P < 0.0001).

Conclusions: Our findings suggest that HIF-1{alpha} may play an important role in aggressive behavior and tumor angiogenesis in GIST. In addition, high expression of HIF-1{alpha} was significantly correlated with tumor recurrence/distant metastasis, so it may provide an ancillary prognostic factor for GIST.

Key Words: gastrointestinal stromal tumor • hypoxia inducible factor-1 alpha (HIF-1{alpha}) • immunohistochemistry, microvessel density (MVD) • vascular endothelial growth factor (VEGF)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Sumiyoshi, Y. Kakeji, A. Egashira, K. Mizokami, H. Orita, and Y. Maehara
Overexpression of Hypoxia-Inducible Factor 1{alpha} and p53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer
Clin. Cancer Res., September 1, 2006; 12(17): 5112 - 5117.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.